Arthritis Foundation Announces Amgen And Wyeth To Be Presenting Sponsor Of The 2008 Arthritis Walk(R)

The Arthritis Foundation, the leading health organization addressing
the needs of 46 million Americans living with arthritis, announced that Amgen and Wyeth
Pharmaceuticals, co-marketers of Enbrel® (etanercept), will be the national presenting sponsor of the
2008 Arthritis Walk®.


"The Arthritis Foundation hosts hundreds of Arthritis Walk events nationwide to raise funds to
prevent, control and cure arthritis, the nation's most common cause of disability," said Becky Burkett,
chief development officer of the Arthritis Foundation. "This generous sponsorship from Amgen and
Wyeth will provide a unique opportunity to generate awareness about arthritis while raising funds that are
critical to helping find a cure for this debilitating condition."


As part of the sponsorship, the Arthritis Foundation will launch a new program in which the
organization will reach out to rheumatologists and members of the Association of Rheumatology Health
Professionals in an effort to help boost attendance and awareness of the Arthritis Walk by encouraging
doctors and their patients to walk together.


"We're excited to have the opportunity to support a program that benefits the entire arthritis
community," said Jeffrey M. Melin, M.D., M.P.H., senior director, Musculoskeletal and Inflammatory
Diseases, Wyeth Research. "We encourage people with arthritis to join the Arthritis Walk together with
their doctor, as well as their friends and family, and to take an active role in improving their own health,
while raising awareness and funding for arthritis research."


"Arthritis can pose challenges to physical activity, but it does not have to mean the end of an
active and healthy lifestyle," said Scott Baumgartner, M.D., director, Global Development, Inflammation
Therapeutic Area, Amgen. "We hope that together with the Arthritis Foundation we can empower and
motivate people with rheumatoid arthritis to consult with their rheumatologist and start or restart an
appropriate fitness program."


Arthritis Walk events, which take place nationwide, kick off National Arthritis Month in May.
Walking as little as 30 minutes - even 10 minutes three times a day - can be beneficial for everyone
and may ease joint pain and improve mobility. For people with arthritis, experts believe that light
exercise such as walking may decrease fatigue, strengthen bones and muscles, and enhance flexibility
and stamina. To sign up for an Arthritis Walk event, visit arthritis.


While often referred to as if it were a single disease, arthritis is actually an umbrella term used for
a group of more than 100 medical conditions that collectively affect the joints of nearly 46 million adults
and 300,000 children in America alone. Osteoarthritis, the most common form of arthritis, is most
prevalent in people over 60 years of age, while rheumatoid arthritis appears primarily in women in their
young- to mid-adult years. Juvenile rheumatoid arthritis is the most common form of arthritis in children.















About the Arthritis Foundation


The Arthritis Foundation is the leading health organization addressing the needs of some 46
million Americans living with arthritis, the nation's most common cause of disability. Founded in 1948,
with headquarters in Atlanta, the Arthritis Foundation has multiple service points located throughout the
country.


The Arthritis Foundation is the largest private, not-for-profit contributor to arthritis research in
the world, funding more than $380 million in research grants since 1948. The foundation helps
individuals take control of arthritis by providing public health education; pursuing public policy and
legislation; and conducting evidence-based programs to improve the quality of life for those living with
arthritis.

arthritis


About Amgen and Wyeth


Amgen and Wyeth Pharmaceuticals, a division of Wyeth, market ENBREL in North America.
Wyeth markets ENBREL outside of North America. Immunex Corporation, a wholly owned subsidiary of
Amgen, manufactures ENBREL, which may be used to treat rheumatoid arthritis, junior rheumatoid
arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis. Additional information about ENBREL,
including the full U.S. Prescribing Information, can be found on the Web site sponsored by the companies
at enbrel.


Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology
pioneer since 1980, Amgen was one of the first companies to realize the new science's promise
by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen
therapeutics have changed the practice of medicine, helping millions of people around the world
in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With
a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing
science to dramatically improve people's lives. To learn more about Amgen's pioneering science
and vital medicines, visit amgen.


Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of
women's health care, infectious disease, gastrointestinal health, central nervous system,
inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products. Wyeth is
one of the world's largest research-driven pharmaceutical and health care products companies. It
is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals,
vaccines, biotechnology products and non-prescription medicines that improve the quality of life
for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth
Consumer Healthcare and Fort Dodge Animal Health.

Wyeth Pharmaceuticals


View drug information on Enbrel.